- Hot Pursuit
SJVN leads gainers in 'A' group
Colgate Palmolive (India), Aurobindo Pharma, Idea Cellular and Opto Circuits (India) are among the other gainers.
Hydro-electric power producer SJVN rose 3.90% to Rs 21.30. The stock topped the gainers in the BSE's 'A' group.
Oral and dental hygiene products maker Colgate-Palmolive (India) rose 3.55% to Rs 1,491.65. The stock was second biggest gainer in 'A' group. The stock hit a record high of Rs 1,499 in intraday today, 20 December 2012.
Aurobindo Pharma rose 3.53% to Rs 195.10. The stock was third biggest gainer in 'A' group. Aurobindo Pharma, during trading hours on Tuesday, 18 December 2012, announced that it has received final approval from the USFDA to manufacture and market the earlier tentatively approved Abacavir Tablets USP 300 milligrams in the US.
Abacavir tablets are the generic equivalent of ViiV Healthcare company's Ziagen Tablets 300 mg and is indicated as part of antiretroviral (ARV) combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected adults and children. The annual sale of Abacavir Tablets USP 300 mg is approximately $88 million in US.
India's third largest listed telecom operator by sales Idea Cellular rose 3.51% to Rs 98.90. The stock was fourth biggest gainer in 'A' group.
Healthcare equipment maker Opto Circuits (India) rose 3.36% to Rs 109.25. The stock was fifth biggest gainer in 'A' group.
Opto Circuits (India) during market hours today, 20 December 2012, said its board approved issuing 20 lakh convertible warrants to Vinod Ramnani at Rs 145 per convertible warrant or as per the pricing formula as stipulated in Sebi's (ICDR) Regulations 2009, which ever is higher.
Vinod Ramnani, the promoter and Chairman & Managing Director of Opto Circuits (India), owned 14.05% stake of the total promoter stake of 28.17% in the company as at 30 September 2012.
Powered by Capital Market - Live News
Get Top 500 Company Research from acclaimed IIFL Research Team...Click Here!!!
India Infoline Research Team / 10:47, Aug 24, 2015
In spite of massive improvement in CV demand, standalone revenues for Banco Products Ltd registered muted performance with sales at Rs. 113cr in Q1 FY16.